Exact Mass: 502.07385800000003
Exact Mass Matches: 502.07385800000003
Found 94 metabolites which its exact mass value is equals to given mass value 502.07385800000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6'-O-Malonyldaidzin
Present in soy foods; potential nutriceutical. 6-Malonyldaidzin is found in many foods, some of which are soy milk, soy sauce, soy bean, and soy yogurt. 6-O-Malonyldaidzin is found in miso. 6-O-Malonyldaidzin is present in soy foods; potential nutriceutical.
Garciduol B
Garciduol B is found in fruits. Garciduol B is a constituent of Garcinia dulcis (mundu). Constituent of Garcinia dulcis (mundu). Garciduol B is found in fruits.
Apigenin 7-(2-acetyl-6-methylglucuronide)
9,10-Anthracenedione, 8-[[6-O-(2-carboxyacetyl)-beta-D-glucopyranosyl]oxy]-1-hydroxy-3-methyl-
7-O-[6-O-(3,4-dihydroxycinnamoyl)-beta-D-glucopyranosyl]-8-hydroxycoumarin
13-hydroxy-7-(6-O-sulfate-beta-D-glucopyranosyl)desoxyhemigossypol
C21H26O12S (502.11449160000006)
Cys Cys Asp Tyr
Cys Cys Tyr Asp
Cys Asp Cys Tyr
Cys Asp Tyr Cys
Cys Tyr Cys Asp
Cys Tyr Asp Cys
Asp Cys Cys Tyr
Asp Cys Tyr Cys
Asp Tyr Cys Cys
Tyr Cys Cys Asp
Tyr Cys Asp Cys
Tyr Asp Cys Cys
Garciduol B
1,3-Benzodithiol-2-yltriphenyl phosphonium tetrafluoroborate
3,5-Bis(3,5-dimethoxybenzyloxy)benzyl Bromide
C25H27BrO6 (502.09909020000003)
Tafamidis meglumine
C21H24Cl2N2O8 (502.09096439999996)
C87006 - Pharmacological Chaperone
Fisogatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor D000970 - Antineoplastic Agents
Capmatinib Hydrochloride
C23H21Cl2FN6O2 (502.10869979999995)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Bis[5-chloro-1H-indol-2-YL-carbonyl-aminoethyl]-ethylene glycol
Malonyldaidzin
A glycosyloxyisoflavone that is daidzein substituted by a 6-O-(carboxyacetyl)-beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage.
Diacetylchitobiose-6-phosphate(2-)
C16H27N2O14P-2 (502.11998520000003)
3-[acetyl(hydroxy)amino]propyl-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyphosphinic acid
7-Methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(3,4,5-trihydroxyphenyl)-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one
4-Chloro-3-(trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester
C24H14ClF3N2O3S (502.0365720000001)
[2-[(4-Fluorophenyl)methylamino]-2-oxoethyl] 1-[2-(trifluoromethyl)phenyl]sulfonylpiperidine-4-carboxylate
C22H22F4N2O5S (502.11854900000003)
N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide
4-[4-[(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]-2-hydroxybenzoic acid
7-methyl-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(3,4,5-trihydroxyphenyl)-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one
beta-D-Galp3S-(1->4)-beta-D-Glcp6S
A glycosylglucose derivative that is beta-lactose bearing two sulfo substituents at position 3 of the galactosyl residue and position 6 of the glucose.
beta-D-Galp6S-(1->4)-beta-D-Glcp6S
A glycosylglucose derivative that consists of 6-sulfated beta-D-glucose having a 6-sulfated beta-D-galactosyl residue attached at position 4.
4-Demethyl-7-(3-amino-3-carboxypropyl)wyosine 5-monophosphate
A ribonucleoside 5-monophosphate having (2S)-2-amino-4-(6-methyl-9-oxo-4,9-dihydro-3H-imidazo[1,2-a]purin-7-yl)butanoic acid as the nucleobase.
7-[(3S)-3-azaniumyl-3-carboxylatopropyl]-6-methyl-3-(5-O-phosphono-beta-D-ribofuranosyl)-3,4-dihydro-9H-imidazo[1,2-a]purin-9-one
6-[(3-Carboxy-3-hydroxy-2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propanoyl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
C20H22O15 (502.09586620000005)
6-[1-(3,4-Dihydroxyphenyl)-3-(4-methoxy-1-benzofuran-5-yl)-1,3-dioxopropan-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
1-[1-(2-chlorophenyl)-3-(pyridin-3-yl)-4,5-dihydro-1H-[1,3]thiazolo[4,5-g]indazol-7-yl]-3-(1H-imidazol-2-ylmethyl)urea
C24H19ClN8OS (502.10909940000005)
2-[(3-{4-[(6-Carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-3-methoxyphenyl}prop-2-enoyl)oxy]-3-hydroxybutanedioic acid
C20H22O15 (502.09586620000005)
4-demethyl-7-(3-amino-3-carboxypropyl)wyosine 5-monophosphate zwitterion
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of 4-demethyl-7-(3-amino-3-carboxypropyl)wyosine 5-monophosphate.
GSK2647544
GSK2647544 is an orally available, selective inhibitor of Lp-PLA2. Lipoprotein-associated phospholipase (Lp-PLA2) is a calcium-independent phospholipase A2 with proinflammatory activities that is primarily secreted by monocyte-derived macrophages[1].
SMS1-IN-1
C23H23BrN2O4S (502.05618180000005)
SMS1-IN-1, compound SAPA 1j, is a novel and the most potent sphingomyelin synthase 1 (SMS1) inhibitor with an IC50 value of 2.1 μM. SMS1-IN-1 has the potential for the treatment of atherosclerosis[1].
2,3,5,6,8-pentahydroxy-7-[1-(1,3,4,6,7-pentahydroxy-5,8-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione
3-oxo-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-8-yl]oxan-2-yl]methoxy}propanoic acid
7-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-(3,4,5-trihydroxyphenyl)-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),3,5(13),6,9-pentaen-11-one
7,9,13,20,24,26-hexahydroxynonacyclo[16.12.0.0²,¹⁵.0³,¹².0⁴,²⁹.0⁵,¹⁰.0⁶,²⁷.0²¹,³⁰.0²³,²⁸]triaconta-1(18),2,4(29),5(10),6,8,12,14,19,21(30),23,25,27-tridecaene-11,22-dione
methyl 5-(acetyloxy)-3,4-dihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylate
5,7-dihydroxyflavone; 7-o-(6-o-malonyl-beta-d-glucopyranoside)
{"Ingredient_id": "HBIN011308","Ingredient_name": "5,7-dihydroxyflavone; 7-o-(6-o-malonyl-beta-d-glucopyranoside)","Alias": "NA","Ingredient_formula": "C24H22O12","Ingredient_Smile": "NA","Ingredient_weight": "502.42","OB_score": "NA","CAS_id": "162101-61-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7704","PubChem_id": "NA","DrugBank_id": "NA"}
(3,4,5-trihydroxy-6-{[6-hydroxy-7-(1-hydroxypropan-2-yl)-10-methyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),4(12),5,7,9-pentaen-5-yl]oxy}oxan-2-yl)methoxysulfonic acid
C21H26O12S (502.11449160000006)
4-bromo-2-{2-[3-bromo-6-(2-chloro-1-hydroxyethyl)-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol
C19H33Br2ClO3 (502.0484818000001)
2,3-dihydroxy-2,3-bis[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]butanedioic acid
[(1s)-2-(3,5-dibromo-4-methoxyphenyl)-1-{[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl]trimethylazanium
[C18H26Br2N5O2]+ (502.0453116)
{3,4,5-trihydroxy-6-[(8-hydroxy-2-oxochromen-7-yl)oxy]oxan-2-yl}methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
2,5,6,7,8-pentahydroxy-3-[1-(3,5,6,7,8-pentahydroxy-1,4-dioxonaphthalen-2-yl)ethyl]naphthalene-1,4-dione
methyl (2s,3s,4s,5s,6s)-5-(acetyloxy)-3,4-dihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylate
3-oxo-3-({3,4,5-trihydroxy-6-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-8-yl]oxan-2-yl}methoxy)propanoic acid
2',4,4',6,6'-pentakis(acetyloxy)-[1,1'-biphenyl]-2-yl acetate
(4s,8r)-16-{[(2s,3r,4r,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2,18-dihydroxy-7,9-dioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1(12),2,10,14,16,18-hexaene-13,20-dione
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-({6-hydroxy-7-[(2s)-1-hydroxypropan-2-yl]-10-methyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),4(12),5,7,9-pentaen-5-yl}oxy)oxan-2-yl]methoxysulfonic acid
C21H26O12S (502.11449160000006)
4,5-dihydroxy-6-{[5-(4-hydroxy-2-oxopyrimidin-1-yl)-4-(c-hydroxycarbonimidoyloxy)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy}-5,6-dihydro-4h-pyran-2-carboxylic acid
10,23-dichloro-16-methoxyhexacyclo[13.9.3.1²,⁶.0⁹,¹⁴.0¹⁸,²⁶.0²¹,²⁵]octacosa-1(24),2(28),3,5,9,11,13,15(27),16,18(26),19,21(25),22-tridecaene-3,13,24-triol
C29H20Cl2O4 (502.07385800000003)
(1r,4s,5s,11r,14s,15s)-15-(acetyloxy)-1,11-bis(methylsulfanyl)-2,12-dioxo-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-6,8,16,18-tetraen-5-yl acetate
3-oxo-3-{[(2r,3s,4s,5r)-3,4,5-trihydroxy-6-{[3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxan-2-yl]methoxy}propanoic acid
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(8-hydroxy-2-oxochromen-7-yl)oxy]oxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
3-oxo-3-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxy]oxan-2-yl]methoxy}propanoic acid
16-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-2,18-dihydroxy-7,9-dioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1(12),2,10,14,16,18-hexaene-13,20-dione
methyl (2s,3s,4s,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylate
(1r,2r,4r)-4-bromo-2-{2-[(2s,3r,6s)-3-bromo-6-[(1s)-2-chloro-1-hydroxyethyl]-2,6-dimethyloxan-2-yl]ethyl}-3,3-dimethylcyclohexan-1-ol
C19H33Br2ClO3 (502.0484818000001)